Liron Boyman

Liron Boyman is an Adjunct Assistant Professor in the Department of Pharmacology and Physiology at the University of Maryland School of Medicine, where he maintains active research affiliations with the BioMET-Center for Biomedical Engineering and Technology in Baltimore, MD.

His academic journey includes:

• B.Sc. in Medical and Life Sciences from Tel Aviv University School of Medicine and Faculty of Life Sciences, Israel (2004)
• Ph.D. in Physiology and Pharmacology from Tel Aviv University School of Medicine, Israel (2010)
• Postdoctoral Fellowship at BioMET-Center for Biomedical Engineering and Technology, University of Maryland (2010-2015)

Dr. Boyman's research centers on cardiac calcium signaling mechanisms, with groundbreaking contributions to understanding mitochondrial calcium dynamics in cardiac cells. He pioneered novel imaging technologies for high-resolution calcium measurements, including genetically targeted mitochondrial probes and oxygen microsensors for ischemia studies. His work bridges fundamental discoveries in excitation-contraction coupling with pathophysiological implications for heart failure and arrhythmias.

Analysis of his 15 most recent publications (2023-2025) reveals expanding research frontiers beyond cardiac physiology into cancer metastasis mechanisms and organelle crosstalk. Key trends include calcium-dependent tumor dissemination via P2Y2 signaling, lysosomal calcium's role in arrhythmias, and mitochondrial-peroxisome interactions mediated by MARCH5. His work consistently integrates advanced imaging with molecular physiology across cardiac, metabolic, and oncological contexts.

His scientific recognition includes:

• Ph.D. Stipend Award from Dr. Miriam and Sheldon G. Edelson Foundation (2004-2010)
• Katzir-Katchalsky Award for Student Travel Fellowships (2008)
• Shtacher Award for Research Excellence (2009)
• American Heart Association Scientist Development Grant (2014)

Dr. Boyman has secured significant competitive funding as Principal Investigator on an AHA grant investigating mitochondrial calcium signaling in heart disease (2015-2019), and as collaborator on NIH-funded projects including sepsis research (2018-2021) and xenotransplantation studies (2020-2025). His laboratory maintains extensive collaborative networks for implementing novel imaging tools across multiple disease models.

He operates within the BioMET-Center for Biomedical Engineering and Technology, leveraging its infrastructure for developing cutting-edge cellular imaging methodologies and investigating calcium dynamics in cardiac and non-cardiac systems.